ADC Therapeutics SA (ADCT)
NYSE
| 日付 | 保有者名 | 取引株数 | 金額レンジ ($) | 取引種別 | 価格レンジ ($) | 届出終了時の株数 | % 変化 |
|---|---|---|---|---|---|---|---|
| 2026-04-02 | Redmile Group, LLC法人 | -5.16M | 16.93M | 売り | 3.28 | 12.68M | -28.94% |
| 2026-03-31 | Redmile Group, LLC法人 | -716.42k | 2.70M | 売り | 3.75 - 3.80 | 12.68M | -5.35% |
| 2026-02-13 | Ms. Lisa Michelle KalleboCorporate Controller & CAO | -5.43k | 21.68k | Sale to Issuer | 3.99 | 37.39k | -12.69% |
| 2026-02-13 | Dr. Mohamed ZakiChief Medical Officer | -24.60k | 98.17k | Sale to Issuer | 3.99 | 243.88k | -9.16% |
| 2026-02-13 | Mr. Jose I. CarmonaCFO | -25.88k | 103.26k | Sale to Issuer | 3.99 | 302.78k | -7.87% |
| 2026-02-13 | Mr. Peter J. GrahamSecretary and Chief Legal & Compliance Officer | -33.29k | 132.84k | Sale to Issuer | 3.99 | 179.07k | -15.68% |
| 2026-02-13 | Dr. Ameet MallikCEO & Director | -103.23k | 411.89k | Sale to Issuer | 3.99 | 2.12M | -4.65% |
| 2025-12-06 | Dr. Ameet MallikCEO & Director | -233.15k | 767.05k | Sale to Issuer | 3.29 | 1.32M | -15.02% |
| 2025-12-06 | Mr. Peter J. GrahamSecretary and Chief Legal & Compliance Officer | -49.51k | 162.88k | Sale to Issuer | 3.29 | 139.03k | -26.26% |
| 2025-12-06 | Ms. Lisa Michelle KalleboCorporate Controller & CAO | -7.14k | 23.49k | Sale to Issuer | 3.29 | 28.86k | -19.83% |
| 2025-12-06 | Dr. Mohamed ZakiChief Medical Officer | -41.07k | 135.11k | Sale to Issuer | 3.29 | 191.82k | -17.63% |
| 2025-12-06 | Mr. Jose I. CarmonaCFO | -53.24k | 175.15k | Sale to Issuer | 3.29 | 248.66k | -17.63% |
| 2025-10-27 | Redmile Group, LLC法人 | 3.85M | 0.00 | Open Market Derivative Acquisition | - | 3.85M | - |
| 2025-06-13 | Mr. Ron SquarerChairman of the Board | -15.18k | 54.36k | Sale to Issuer | 3.58 | 53.63k | -22.07% |
| 2025-06-13 | Dr. Victor SandorIndependent Non-Executive Director | -12.60k | 45.11k | Sale to Issuer | 3.58 | 68.29k | -15.58% |
| 2025-06-13 | Ms. Viviane MongesIndependent Non-Executive Director | -2.58k | 9.25k | Sale to Issuer | 3.58 | 104.04k | -2.42% |
| 2025-06-13 | Dr. Peter HugVice-Chairman & Lead Independent Director | -2.14k | 7.68k | Sale to Issuer | 3.58 | 180.50k | -1.17% |
| 2025-06-13 | Dr. Jean-Pierre BizzariIndependent Non-Executive Director | -12.60k | 45.11k | Sale to Issuer | 3.58 | 66.90k | -15.85% |
| 2025-06-13 | Mr. Robert William AzelbyIndependent Director | -12.60k | 45.11k | Sale to Issuer | 3.58 | 40.41k | -23.77% |
| 2025-06-11 | Redmile Group, LLC法人 | 28.20M | 0.00 | Open Market Derivative Acquisition | - | 12.47M | -179.22% |
ご覧いただいた銘柄が下記のボックス内に表示されますので、過去閲覧した銘柄情報に簡単にアクセスすることができます。
顧客サポート: +44 (0) 203 8794 460 | support@advfn.com
ADVFNのサービスをご利用いただくには、利用規約
すでにアカウントをお持ちですか? サインイン
アカウントをお持ちでないですか? 登録
登録することで、ADVFN の 利用規約 を読み、理解し、同意したこと、および私が個人投資家であることを確認します。